Literature DB >> 9473105

Effect of prenatal glucocorticoids on pulmonary vascular muscularisation in nitrofen-induced congenital diaphragmatic hernia.

B O Okoye1, P D Losty, D A Lloyd, J R Gosney.   

Abstract

BACKGROUND/
PURPOSE: Pulmonary hypertension (PH) contributes significantly to the mortality of congenital diaphragmatic hernia (CDH). Pulmonary vascular changes in CDH include a reduced vascular bed with increased arterial medial wall thickness and peripheral extension of muscle into intraacinar vessels. Antenatal steroids improve biochemical immaturity, lung compliance, and morphology in experimental CDH animals. The aim of this study was to examine the effects of prenatal glucocorticoid therapy on pulmonary artery muscularisation in CDH rats.
METHODS: CDH was induced in fetal rats by the maternal administration of 100 mg of nitrofen by gavage on day 9.5 of gestation (term, day 22). Control animals received olive oil (OO). Dexamethasone (Dex, 0.25 mg/kg) or normal saline (NS) was given by intraperitoneal injection on days 18.5 and 19.5, and fetuses were delivered by caesarean section on day 21.5. Lung sections from five fetuses in each of four experimental groups were studied by a blinded investigator- OO-NS controls, CDH-NS, CDH-Dex, and non-CDH-NS. The external diameter (ED), medial wall thickness (MT), percent of medial wall thickness, and wall structure were evaluated from preacinar arteries accompanying conducting airways, and the intraacinar arterioles associated with the respiratory bronchi and saccules.
RESULTS: In the preacinar arteries, CDH-NS animals had a significantly increased MT percentage compared with OO-NS controls (21.2+/-8.8 v 17.8+/-10.3, P = .0001). CDH-Dex rats had a lower MT percentage than CDH-NS rats (15.5+/-6.7 v 21.2+/-8.8, P = .0001). In the intraacinar region, CDH-Dex fetuses had a reduced percentage of muscularised intraacinar blood vessels compared with CDH-NS and OO-NS controls (10% v 24% and 28%, respectively, P = .01). Dexamethasone-treated CDH pups also displayed a significantly lower MT percentage of the intraacinar arteries compared with CDH-NS and OO-NS animals (15.7+/-13 v 23.4+/-9 and 25.4+/-12, P = .003).
CONCLUSIONS: Medial hypertrophy is present in the preacinar but not the intraacinar blood vessels of CDH rats before birth. Dexamethasone inhibits medial hypertrophy and reduces the number of muscularised intraacinar vessels. Antenatal glucocorticoids may reduce the risk of PH developing in human newborns with antenatally diagnosed CDH.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9473105     DOI: 10.1016/s0022-3468(98)90366-9

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  10 in total

1.  Effect of antenatal tetramethylpyrazine on lung development and YAP expression in rat model of experimental congenital diaphragmatic hernia.

Authors:  Junzuo Liao; Wenying Liu; Libin Zhang; Qin Li; Fang Hou; Pingjin Zou
Journal:  Int J Clin Exp Pathol       Date:  2020-01-01

2.  Structure and epitope distribution of heparan sulfate is disrupted in experimental lung hypoplasia: a glycobiological epigenetic cause for malformation?

Authors:  Sophie M Thompson; Marilyn G Connell; Toin H van Kuppevelt; Ruoyan Xu; Jeremy E Turnbull; Paul D Losty; David G Fernig; Edwin C Jesudason
Journal:  BMC Dev Biol       Date:  2011-06-14       Impact factor: 1.978

3.  Therapeutic potential of mesenchymal stem cell transplantation in a nitrofen-induced congenital diaphragmatic hernia rat model.

Authors:  Ratih Yuniartha; Fatima Safira Alatas; Kouji Nagata; Masaaki Kuda; Yusuke Yanagi; Genshiro Esumi; Takayoshi Yamaza; Yoshiaki Kinoshita; Tomoaki Taguchi
Journal:  Pediatr Surg Int       Date:  2014-08-05       Impact factor: 1.827

4.  Effect of dexamethasone on endothelial nitric oxide synthase in experimental congenital diaphragmatic hernia.

Authors:  B O Okoye; P D Losty; M J Fisher; I Wilmott; D A Lloyd
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-05       Impact factor: 5.747

5.  Increased expression of ICAM-1 and VCAM-1 in the lung of nitrofen-induced congenital diaphragmatic hernia in rats.

Authors:  Kei Unemoto; Masato Sakai; Hideki Shima; Nino Guarino; Prem Puri
Journal:  Pediatr Surg Int       Date:  2003-05-21       Impact factor: 1.827

6.  Improved pulmonary function in the nitrofen model of congenital diaphragmatic hernia following prenatal maternal dexamethasone and/or sildenafil.

Authors:  Carmen Mesas Burgos; Erik G Pearson; Marcus Davey; John Riley; Huimin Jia; Pablo Laje; Alan W Flake; William H Peranteau
Journal:  Pediatr Res       Date:  2016-07-04       Impact factor: 3.756

7.  ANG-1 TIE-2 and BMPR signalling defects are not seen in the nitrofen model of pulmonary hypertension and congenital diaphragmatic hernia.

Authors:  Harriet Jane Corbett; Marilyn Gwen Connell; David Garth Fernig; Paul Damion Losty; Edwin Chitran Jesudason
Journal:  PLoS One       Date:  2012-04-23       Impact factor: 3.240

8.  Aldehyde dehydrogenase 2 protects against oxidative stress associated with pulmonary arterial hypertension.

Authors:  Tao Xu; Shuangyue Liu; Tingting Ma; Ziyi Jia; Zhifei Zhang; Aimei Wang
Journal:  Redox Biol       Date:  2016-12-21       Impact factor: 11.799

9.  Enhanced Pulmonary Vascular and Alveolar Development via Prenatal Administration of a Slow-Release Synthetic Prostacyclin Agonist in Rat Fetal Lung Hypoplasia.

Authors:  Satoshi Umeda; Shigeru Miyagawa; Satsuki Fukushima; Noriko Oda; Atsuhiro Saito; Yoshiki Sakai; Yoshiki Sawa; Hiroomi Okuyama
Journal:  PLoS One       Date:  2016-08-16       Impact factor: 3.240

Review 10.  Congenital diaphragmatic hernias: from genes to mechanisms to therapies.

Authors:  Gabrielle Kardon; Kate G Ackerman; David J McCulley; Yufeng Shen; Julia Wynn; Linshan Shang; Eric Bogenschutz; Xin Sun; Wendy K Chung
Journal:  Dis Model Mech       Date:  2017-08-01       Impact factor: 5.758

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.